The University of Oxford PRINCIPLE trial had to evaluate the potential of repurposed drugs such as Ivermectin, Fluvoxamine, Favipiravir, and many more for early COVID-19 treatment. TrialSite first…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.